TCM Daoyin in the Treatment of Patients With Anxiety State
1 other identifier
interventional
30
1 country
1
Brief Summary
In recent years, the number of people with symptoms of anxiety are on the rise. TCM Daoyin is a promising intervention for anxiety. This study is designed to allow researchers to better understand the changes in anxiety symptom, brain activity, and immune function during patients with anxiety states receiving TCM Daoyin intervention. Thus, the aims of the prospective randomized study are: (1) to examine the effects of TCM Daoyin training on reducing symptoms of anxiety, (2) to measure brain activity by using functional magnetic resonance imaging (fMRI), and (3) to assess Immune function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2023
CompletedStudy Start
First participant enrolled
June 13, 2023
CompletedFirst Posted
Study publicly available on registry
July 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2025
CompletedApril 3, 2025
March 1, 2025
1.8 years
June 11, 2023
March 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
14-item Hamilton Anxiety Rating Scale
The 14-item Hamilton Anxiety Rating Scale (HAMA-14) is a clinician-rated assessment (structured interview) of patients' anxious symptoms. Questions focus on anxious symptoms during the past 7 days, and higher cumulative scores indicate more severe anxiety. The HAMA-14 are rated on 5 grades ranging from 0(no symptom) to 4 (very severe). The total score ranges from 0 to 56. 29 or more on HAMA means severe anxiety disorders, 21 to 28 on HAMA means obvious anxiety disorders, 14 to 20 on HAMA means anxiety disorders, 8 to 13 on HAMA means suspicious anxiety disorders, 7 or less means no anxiety disorders.
Change from Baseline HAMA-14 at 12 weeks
Secondary Outcomes (9)
17-item Hamilton Depression Rating Scale
Change from Baseline HAMD-17 at 12 weeks
Depression, Anxiety and Stress Scale-21 item
Baseline
Depression, Anxiety and Stress Scale-21 item
6 weeks
Depression, Anxiety and Stress Scale-21 item
12 weeks
Functional magnetic resonance imaging (fMRI)
Baseline
- +4 more secondary outcomes
Study Arms (3)
TCM Daoyin intervention group
EXPERIMENTALParticipants randomized to TCM Daoyin intervention group receive health education plus a TCM Daoyin training program. The TCM Daoyin training program was a 12-week, instructor-led group training program.
Health education control group
ACTIVE COMPARATORParticipants randomized to the health education control group only receive health education and no additional training program.
Healthy Control
NO INTERVENTIONHealthy volunteers for data comparison, receiving no intervention.
Interventions
The TCM Daoyin training program consisted of two 90-min training classes and at least five 30-min at-home practice sessions per week for 12-weeks. All sessions included 10 min of warmup and 10 min of cooldown.
Health education is provided by psychologist and TCM doctor, including work, rest, diet and other basic programs.
Eligibility Criteria
You may qualify if:
- Subject with a primary mental health complaint of anxiety.
- Anxiety 14≤HAMA-14≤29, Depression 7≤HAMD-17\<14.
- Subject has no history of psychotropic medication or has been off medication for more than 6 months.
- Right-handed, aged 18 to 65, male or female.
- Subject has a clear mind and the ability to lead an independent life.
- Subject agrees to participate in fMRI scan and provide signed informed consent.
You may not qualify if:
- Subject with definite clinical diagnosis of anxiety disorder and depression disorder by ICD-10.
- Subject with bipolar disorder, psychotic disorder (e.g., schizophrenia), organic mental disorder (e.g., Alzheimer's disease).
- Subject with alcohol abuse, substance dependence and suicidal ideation in past-year, or currently taking psychiatric medication, or current serious suicidal attempt.
- Subject with serious current unstable medical illness.
- Subject has claustrophobia, or any contraindication unable or unwilling to participate in fMRI scan.
- Subject is clinically unable to participate in TCM Daoyin training program.
- Subject is pregnant or lactating women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Qigong Research Institute
Shanghai, Shanghai Municipality, 021, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessors were blinded to the group allocation of the participants.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant researcher
Study Record Dates
First Submitted
June 11, 2023
First Posted
July 6, 2023
Study Start
June 13, 2023
Primary Completion
March 20, 2025
Study Completion
March 20, 2025
Last Updated
April 3, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share